# Gluconeogenesis: Pushing Glucose Back Uphill

> Gluconeogenesis is how the body builds glucose from non-sugar parts, a job that matters most when food runs out, and its single organizing idea is that it is not glycolysis run backward. It shares seven near-equilibrium enzymes with glycolysis but routes around the three one-way glycolytic steps with four different enzymes, working across three compartments and spending enough ATP and GTP that the whole pathway runs downhill toward glucose. Because both pathways are then downhill, the cell has to choose between them by regulation at each enzyme pair, so in a healthy liver cell one direction dominates and wasteful cycling stays small.

Course: Biochemistry (Central Metabolism). Level: university elective. About 27 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/gluconeogenesis/

Builds on: Glycolysis: The Investment-and-Payoff Pathway · Metabolism: Basic Concepts and Design · Basic Concepts of Enzyme Action

## What you'll learn

- Explain why the brain and red blood cells force the body to make new glucose during fasting, and name the three classes of precursor (lactate, glucogenic amino acids, glycerol) and where each enters the pathway.
- Defend the claim that gluconeogenesis is NOT glycolysis in reverse by identifying the three irreversible glycolytic steps and the four bypass enzymes (pyruvate carboxylase, PEPCK, FBPase-1, glucose-6-phosphatase) that replace them.
- Tally the energetic cost of one glucose made from two pyruvates (4 ATP + 2 GTP + 2 NADH) and contrast it with the +2 ATP yield of glycolysis.
- Explain why both pathways are downhill and so must be regulated, how fructose-2,6-bisphosphate and the bifunctional PFK-2/FBPase-2 enzyme switch the middle enzyme pair, and what controls the pyruvate and glucose pairs.

**Skip breakfast and lunch, and by the early afternoon your liver is building much of your glucose out of spare parts.** It has to. Your brain runs almost entirely on glucose until a fast lasts several days and ketones take over part of the load, and your red blood cells, which have no mitochondria, run on nothing else. Glycogen breakdown supplies most of the glucose in the first hours of a fast, with gluconeogenesis already contributing; gluconeogenesis rises as glycogen falls, and the two share the load until glycogen runs low within a day or two. After that, blood sugar stays in its narrow lane (about 70–100 mg/dL fasting) only because the liver, with help from the kidney cortex, is manufacturing fresh glucose. (When the film at the top says the body “switches”, it means this gradual handover.) Fasting is not running out of energy but switching fuels: gluconeogenesis supplies the glucose-dependent tissues while most others switch to fat and ketones.

On a map, gluconeogenesis looks like glycolysis run backward. That raises two puzzles. If glycolysis runs downhill, its steps run backward should run uphill, so how does the liver make glucose from pyruvate at all? And once it can, what stops a liver cell from making glucose and burning it at the same time?

## Where the carbons come from

There are three precursors to know. **Lactate** comes back from hard-working muscle and red cells; lactate dehydrogenase converts it to pyruvate. **Glucogenic amino acids**, alanine chief among them, plus glutamine, the kidney’s main gluconeogenic amino acid, lose their nitrogen and enter at pyruvate or at citric acid cycle intermediates that become oxaloacetate. **Glycerol**, released when fat is mobilized, enters as dihydroxyacetone phosphate (DHAP) by way of glycerol kinase and glycerol-3-phosphate dehydrogenase.

Notice what is missing: the fatty acids that make up most of fat. Even-chain fatty acids cannot become glucose. This trips up almost everyone; the reason comes after Bypass 1.

## Three cliffs: why the pathway can’t just run backward

An enzyme speeds a reaction both ways; it does not pick a direction. ΔG, the free-energy change under the conditions inside the cell, does. When ΔG is close to zero, the step is **near equilibrium**: a two- or threefold change in concentrations tips it either way, so one enzyme can serve both pathways. When ΔG is large and negative, the step is **far from equilibrium** and in practice runs one way only. That is all “irreversible” means here.

Seven of glycolysis’s ten steps are near equilibrium, and gluconeogenesis shares those seven enzymes. Three are far from it. These are classic estimates of their ΔG inside a cell (calculated from metabolite levels measured in red blood cells; textbooks differ by a few kJ/mol):

| Glycolytic step | What it does | ΔG in the cell |
| --- | --- | --- |
| Hexokinase | ATP’s phosphate onto glucose | about −33 kJ/mol |
| Phosphofructokinase-1 (PFK-1) | ATP’s phosphate onto fructose-6-phosphate | about −22 kJ/mol |
| Pyruvate kinase | PEP’s phosphate onto ADP, making ATP | about −17 kJ/mol |

**Predict.** Could the cell run pyruvate kinase backward just by piling up pyruvate and ATP?

> **Check your prediction.** Only in principle. At body temperature, every 6 kJ/mol or so of ΔG is a tenfold change in the ratio of products to reactants. Just to bring pyruvate kinase to equilibrium the cell would have to shift that ratio about 650-fold, and for hexokinase about 400,000-fold; running either one backward would take more still. No cell can hold its ATP, ADP and sugar phosphates that far from normal.

So at each cliff, gluconeogenesis uses a different enzyme:

- **Where glycolysis put a phosphate on with ATP** (hexokinase, called glucokinase in liver, and PFK-1), gluconeogenesis does not hand the phosphate back to ADP; it cuts it off with water. These hydrolyses, by **glucose-6-phosphatase** and **fructose-1,6-bisphosphatase (FBPase-1)**, are downhill (about −14 and −16 kJ/mol; these are standard values, unlike the table’s in-cell ones).
- **Where glycolysis made ATP** (pyruvate kinase), there is no cheap trick: even with one ATP spent, turning pyruvate back into phosphoenolpyruvate (PEP) is uphill by about 31 kJ/mol under standard conditions (about 17 in the cell, the table’s number with its sign flipped). The cell spends two high-energy phosphates, an ATP at **pyruvate carboxylase** and a GTP at **PEP carboxykinase (PEPCK)**. The second phosphate is worth about 30.5, so with both the step is about even under standard conditions (+31 − 30.5 ≈ +1) and comfortably downhill in the liver.

> **The one idea to carry through this lesson.** Every step has to run downhill in the direction it is used, the near-equilibrium ones only slightly. Gluconeogenesis keeps glycolysis’s seven near-equilibrium steps and swaps each of the three one-way steps for a different reaction that runs downhill toward glucose. With both pathways downhill, thermodynamics no longer picks the direction; the cell has to choose, by regulation.

This holds in the liver and kidney cortex, which carry all four bypass enzymes.

*Figure (AI-generated illustration).* Gluconeogenesis keeps glycolysis's seven near-equilibrium steps and replaces the three one-way steps with four different enzymes (gold), spread over mitochondrion, cytosol and ER. Each lane now runs downhill in its own direction, so thermodynamics no longer decides between them; regulation does. Image: two side-by-side lanes run between glucose at the top and two pyruvates at the bottom, glycolysis pointing down on the left and gluconeogenesis pointing up on the right. They share a central ladder of seven reversible steps, one between the top two splits and six below. At three points the lanes split: glycolysis uses one-way hexokinase, PFK-1 and pyruvate kinase arrows, while gluconeogenesis takes four gold bypass enzymes: glucose-6-phosphatase on an ER band, FBPase-1, and PEPCK above pyruvate carboxylase, which sits on a mitochondrion band. A small inset shows a switch choosing the up direction.

## Bypass 1: pyruvate to PEP, across two compartments

Inside the mitochondrion, **pyruvate carboxylase** adds CO₂ to pyruvate to make oxaloacetate, spending one ATP. It uses biotin, a vitamin that carries the CO₂ (see Going deeper), and is switched on by acetyl-CoA, the cell’s way of saying *plenty of fuel here, make glucose rather than burn more pyruvate.*

Next, a shipping problem. Phosphoenolpyruvate carboxykinase (PEPCK), the next enzyme, works in the cytosol in the route followed here (human liver also has a mitochondrial form), and oxaloacetate has no transporter across the inner mitochondrial membrane. The fix is the **malate shuttle**: oxaloacetate is reduced to malate, malate rides out on the malate–α-ketoglutarate carrier, and in the cytosol it is oxidized back to oxaloacetate.

The trip also moves reducing power, and where the NADH must come from decides whether oxaloacetate leaves as malate or as aspartate. Later, GAPDH runs in reverse and needs a cytosolic NADH for each three-carbon unit. From pyruvate or alanine, that NADH must come out of the mitochondrion, and malate brings it. From lactate, lactate dehydrogenase already made the NADH in the cytosol, so oxaloacetate can leave as aspartate instead.

Back in the cytosol, **PEPCK** spends a GTP and removes the very CO₂ that pyruvate carboxylase added, producing phosphoenolpyruvate.

*Figure (AI-generated illustration).* Bypass 1 takes two enzymes and two compartments. Pyruvate carboxylase spends ATP to add CO₂ in the mitochondrion; oxaloacetate leaves as malate, carrying NADH; PEPCK spends GTP and removes the same CO₂ in the cytosol. Starting from lactate, oxaloacetate can leave as aspartate instead, because lactate dehydrogenase has already made the cytosolic NADH. (Human liver also has a mitochondrial PEPCK, not shown.) Image: inside a mitochondrion, pyruvate carboxylase spends ATP to attach a gold CO2 token to pyruvate, making oxaloacetate, which cannot cross the inner membrane and is converted to malate, carried across with its NADH. In the cytosol malate becomes oxaloacetate again, and PEPCK spends GTP and releases the same gold CO2 token, making PEP. An inset shows that with lactate as the precursor, oxaloacetate leaves as aspartate because the lactate-to-pyruvate step already made NADH in the cytosol.

**Predict.** Why would a cell add a CO₂ only to remove it one step later?

> **Check your prediction.** PEP needs about two high-energy phosphates’ worth of energy, and in animals no single enzyme turns pyruvate into PEP. The CO₂ is the handle that lets two enzymes, in two compartments, share the job. Pyruvate carboxylase spends ATP to attach it, storing energy in oxaloacetate. PEPCK pulls the same CO₂ off; that decarboxylation is downhill, and with a GTP it pays for PEP. That is what “CO₂ as a thermodynamic lever” means.

## Why fat can’t become sugar

Every phosphoenolpyruvate (PEP) made from pyruvate uses up one oxaloacetate, so gluconeogenesis from anything but glycerol (which enters at dihydroxyacetone phosphate (DHAP), above PEP) needs a net source of oxaloacetate or of something that becomes it, such as pyruvate or citric acid cycle intermediates. Even-chain fatty acids supply none. Their carbons enter the citric acid cycle as acetyl-CoA, which joins one oxaloacetate to get in; over a turn, two carbons leave as CO₂ and exactly one oxaloacetate comes back. Net oxaloacetate gain is zero, so net glucose from fatty acids is zero. (Carbon label from a fatty acid can still turn up in glucose, because the cycle shuffles atoms; see the isotope-tracing technique above.)

Why not turn acetyl-CoA back into pyruvate? Pyruvate dehydrogenase releases CO₂ in a step so far downhill that it runs one way only (next chapter). Plants and bacteria have a way around: two glyoxylate-cycle enzymes let acetyl-CoA skip the cycle’s two CO₂-releasing steps, giving them a net gain of oxaloacetate. Humans and other vertebrates lack them. The one exception is odd-chain fatty acids, whose final three-carbon propionyl-CoA can be routed through succinyl-CoA to oxaloacetate. Of the fat you actually carry, only the glycerol backbone can become sugar.

## Bypasses 2 and 3, and why muscle can’t share

From phosphoenolpyruvate (PEP), the shared enzymes run in reverse up to fructose-1,6-bisphosphate. There **FBPase-1** hydrolyzes off a phosphate, a clean snip past the phosphofructokinase-1 (PFK-1) cliff. It is a major regulated step, inhibited by AMP and by fructose-2,6-bisphosphate and activated by citrate.

**Predict.** FBPase-1 makes no ATP and spends none. How can it run downhill, and what did it cost?

> **Check your prediction.** Cutting the phosphate off with water is downhill on its own (the −16 above). Handing it back to ADP, the reverse of PFK-1, would be uphill by about 14, since PFK-1 is downhill by about 14 under standard conditions. The gap, about 30 kJ/mol, is one ATP’s worth: the ATP that PFK-1 spent, which gluconeogenesis never gets back. The cost is a refund given up, not a payment.

The last cliff, **glucose-6-phosphatase**, works the same way, and it hides in a revealing place: the lumen of the endoplasmic reticulum. Glucose-6-phosphate is carried in by the T1 transporter to be dephosphorylated (why there is unsettled; Going deeper). Only liver, kidney cortex and, to a lesser degree, the small intestine express the glucose-releasing form, G6Pase-α. Muscle does not, so it cannot send its glycogen into the blood as glucose; it uses that glycogen locally and, in hard work, ships out the lactate it makes faster than it can use.

*Figure (AI-generated illustration).* T1 transports glucose-6-phosphate into the ER lumen, where the lumen-facing catalytic site of membrane-bound G6Pase-α releases glucose. Liver, kidney cortex and, to a lesser degree, small intestine express this isoform; skeletal muscle lacks it. G6Pase-β is widely expressed. Image: a liver-cell schematic shows glucose-6-phosphate moving from the cytosol through T1 into the ER lumen and being converted to glucose at the lumen-facing catalytic site of membrane-bound G6Pase-α. A skeletal-muscle inset marks G6Pase-α as absent.

## The bill

Count what one glucose costs from two pyruvates. Every step from pyruvate up to the trioses happens twice, once for each three-carbon half.

**Predict.** Before you open the map, count: how many high-energy phosphates and how many NADH does one glucose cost?

> **Check your prediction.** - Pyruvate carboxylase: 1 ATP per pyruvate, so 2.
> - PEPCK: 1 GTP per pyruvate, so 2.
> - Phosphoglycerate kinase, a shared step run in reverse: 1 ATP per pyruvate, so 2.
> - GAPDH, run in reverse: 1 NADH per pyruvate, so 2.
> - FBPase-1 and glucose-6-phosphatase: nothing.
>
> That is **4 ATP + 2 GTP + 2 NADH per glucose**. Two of the six high-energy phosphates are spent at a shared step, which a count of only the bypass enzymes misses.

Check your count: tap each step to reveal it and watch the tally.

*Interactive on the lesson page:* Gluconeogenesis · 11 steps tap a step to reveal it Running total 0 ATP0 NADH0 GTP regulated step − used up Mitochondrial

Glycolysis nets only 2 ATP, so building a glucose costs four more high-energy phosphates than breaking one down returns. (The film calls the six “the extra cost”; six is the total, and four is the extra beyond what glycolysis returns.) Those four make the pathway run. Under standard conditions glycolysis is downhill by about 85 kJ/mol, so running it literally backward would be uphill by 85. Four more high-energy phosphates, at about 30.5 kJ/mol each, turn that into about −37 kJ/mol. Glucose does sit uphill of two pyruvates; the ATP and GTP are the push that makes the coupled climb run downhill.

In the **Cori cycle**, muscle and red cells break glucose to lactate and bank 2 ATP; the liver rebuilds the glucose for 6. Each loop costs the body 4 high-energy phosphates, paid by the liver (in a fast, fueled largely by fat oxidation). Drag the effort slider to send more lactate to the liver and watch the ledger.

*Interactive on the lesson page:* The Cori cycle — borrowing energy from the liver

## Downhill both ways: the switch at each pair

The catch: if both pathways ran at full speed in one cell, glucose would be broken down and rebuilt with no product: a **futile cycle** that burns ATP as heat. Each turn wastes four high-energy phosphates: one at the glucose pair, one at the middle pair, and two at the pyruvate pair (lifting each pyruvate to phosphoenolpyruvate (PEP) costs an ATP and a GTP, and pyruvate kinase returns one ATP). That matches the bill: six spent, two made.

The one idea, in short: **downhill both ways, so the cell has to choose.** As the film puts it, regulation, not the energy cost, holds the cycle in check, and each of the three pairs has its own controls.

**The middle pair, phosphofructokinase-1 (PFK-1) and FBPase-1.** The best-known switch, **fructose-2,6-bisphosphate** (F-2,6-BP), works here, activating PFK-1 and inhibiting FBPase-1. *1,6 is the pathway; 2,6 is the regulator.*

| Enzyme | What it acts on | Wins in the liver when you are |
| --- | --- | --- |
| PFK-1 | makes fructose-1,6-bisphosphate (glycolysis) | fed |
| FBPase-1 | breaks fructose-1,6-bisphosphate (gluconeogenesis) | fasting |
| PFK-2/FBPase-2 | one protein; its two domains make (PFK-2) or break (FBPase-2) fructose-2,6-bisphosphate | fed: PFK-2; fasting: FBPase-2 |

In the fed liver, insulin keeps this **bifunctional enzyme** dephosphorylated, the kinase wins, F-2,6-BP rises, and glycolysis runs.

*Figure (AI-generated illustration).* Fed versus fasting at the middle pair. Insulin leaves the bifunctional enzyme dephosphorylated: the kinase makes fructose-2,6-bisphosphate, which activates PFK-1 and inhibits FBPase-1. Glucagon, through PKA, phosphorylates it: the phosphatase destroys fructose-2,6-bisphosphate and FBPase-1 runs. 1,6 is the pathway; 2,6 is the regulator. Image: two side-by-side panels, Fed (insulin) and Fasting (glucagon). In the fed panel the bifunctional PFK-2/FBPase-2 protein is unphosphorylated with its kinase lobe outlined, gold fructose-2,6-bisphosphate tokens activate PFK-1 and block FBPase-1, and the PFK-1 arrow from fructose-6-phosphate to fructose-1,6-bisphosphate is thick. In the fasting panel PKA has added a phosphate, the phosphatase lobe is outlined, fructose-2,6-bisphosphate is gone, and the FBPase-1 arrow back to fructose-6-phosphate is thick.

**The pyruvate pair.** Liver pyruvate kinase is shut off when protein kinase A (PKA) phosphorylates it; fructose-1,6-bisphosphate activates it, and ATP and alanine inhibit it. Pyruvate carboxylase is switched on by acetyl-CoA.

**The glucose pair** is set by glucokinase’s regulatory protein, which pulls glucokinase into the nucleus when glucose is low, and by enzyme amounts that insulin and glucagon control over hours.

**Predict.** A fast begins. Glucagon raises cAMP and activates PKA, and the liver burns fat, so its acetyl-CoA rises. Predict the middle and pyruvate pairs.

> **Check your prediction.** - **Middle pair:** PKA phosphorylates the bifunctional enzyme, the phosphatase wins, and F-2,6-BP falls. PFK-1 loses its activator and FBPase-1 is released.
> - **Pyruvate pair:** PKA shuts off liver pyruvate kinase, so new PEP is not turned back into pyruvate, and acetyl-CoA turns on pyruvate carboxylase.
> - **Glucose pair:** glucokinase is sequestered as glucose falls, and over hours enzyme amounts shift toward glucose-6-phosphatase.
>
> So in a healthy liver cell one direction dominates and the waste stays small. Notice that “fasting” and “energy high” point the same way: burning fat supplies the liver’s ATP and acetyl-CoA, and while its energy state stays high, AMP stays low, which also leaves FBPase-1 free.

## When a bypass breaks

**Pyruvate carboxylase deficiency** breaks Bypass 1: pyruvate cannot be carboxylated to start gluconeogenesis, so it piles up and is converted to lactate, and lactic acidosis is the constant finding. In the severe newborn form hypoglycemia often joins it, with high ammonia, because the same oxaloacetate also feeds the citric acid cycle and, as aspartate, the urea cycle.

**Von Gierke disease** (glycogen storage disease type I) breaks Bypass 3. Without glucose-6-phosphatase or its T1 transporter, the liver can build glucose-6-phosphate but cannot release free glucose through its usual route: severe fasting hypoglycemia, lactic acidosis, and a liver swollen with glycogen it cannot cash out.

In **type 2 diabetes** no enzyme is missing. Insulin no longer holds the liver’s glucose output down, and fasting blood sugar rises; much of the cause is extra fuel arriving from fat.

The **alanine cycle**, beside the Cori cycle, carries muscle nitrogen to the liver packaged on alanine, because muscle lacks the urea-cycle machinery to dispose of ammonia. A rising serum alanine aminotransferase (ALT), the enzyme that runs that cycle, flags liver damage.

In the next chapter we follow pyruvate the other way, into the mitochondrion, where the pyruvate dehydrogenase complex turns it irreversibly into acetyl-CoA, which the citric acid cycle can burn completely.

## Going deeper

### The swinging biotin arm of pyruvate carboxylase

Pyruvate carboxylase uses a biotin cofactor on a flexible lysine tether, carried on a mobile domain that swings the carboxyl group between two active sites. At the first site the enzyme spends its ATP to load CO₂ onto biotin; at the second, biotin hands the carboxyl to pyruvate, making oxaloacetate.

### Why glucose-6-phosphatase sits in the ER lumen

The reason is not settled. Hexokinase (glucokinase, in liver) sits in the cytosol running the opposite reaction, but both enzymes draw on the same pool of glucose-6-phosphate, so the separate room does not by itself stop a futile cycle; regulation of the two enzymes does most of that work.

### Type 2 diabetes, PEPCK and metformin

Much of the liver’s lost insulin response is indirect. Insulin-resistant fat releases more glycerol and fatty acids, the fatty acids raise liver acetyl-CoA and so pyruvate carboxylase flux, and glucagon stays high. Phosphoenolpyruvate carboxykinase (PEPCK) levels alone control surprisingly little of the flux. Metformin lowers glucose output, by mechanisms still debated (AMPK activation is one candidate, a drop in liver energy state another).

### Fasting across cultures

Fasting itself is old and human. The Teton Sioux fasted to invite a spiritual awakening, and cultures across the world still fast for clarity or devotion. Every such fast runs on the handover this lesson opened with: glycogen and gluconeogenesis first, then, after several days, ketones taking over part of the brain’s load.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/gluconeogenesis/
